Allelic frequencies of six polymorphic markers for risk of prostate cancer

Brazilian Journal of Medical and Biological Research

Volumn 35, Issue 2, 2002, Pages 205-213

  Ribeiro, M L ^a   Santos, A ^a   Carvalho Salles, A B ^b   Hackel, C ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Hemocentro   (Brazil)

Author keywords

AR; CYP17; Polymorphisms; Prostate cancer; SRD5A2

Indexed keywords

ADENINE; ALANINE; ANDROGEN RECEPTOR; CYTOCHROME P450C17; CYTOSINE; GUANINE; LEUCINE; THREONINE; VALINE;

ADULT; ALLELE; ARTICLE; AUTOSOME; BRAZIL; CANCER RISK; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; EUROPE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; NORTH AMERICA; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRINUCLEOTIDE REPEAT;

EID: 0036124523     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2002000200009     Document Type: Article

References (40)

1. Estimativa de incidência e mortalidade por câncer no Brasil
2. Prostate cancer and work environment
3. Dietary betacarotene, vitamin C, and risk of prostate cancer: Results from the Western electric study
4. Case-control study of risk factors for prostate cancer
5. Prostate cancer and smoking: A review of case-control and cohort studies
6. Estimates of the worldwide incidence of eighteen major cancers in 1985
7. Androgen metabolism and prostate cancer: Establishing a model of genetic susceptibility
8. The importance of steroid hormones in prostate cancer
9. Androgen receptor defects: Historical, clinical, and molecular perspectives
10. Cloning and sequence of the human gene for P450c17 (steroid 17α-hydroxylase/17,20 lyase): Similarity with the gene for P450c21
11. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17
12. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element
13. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups
14. Trinucleotide (GGN) repeat polymorphism in the androgen receptor gene
15. n-expanded neuropathies
16. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
17. Polymorphic repeats in the androgen receptor gene: Molecular markers of prostate cancer risk
18. The androgen receptor gene GGN microsatellite and prostate cancer risk
19. Molecular genetics of steroid 5α-reductase 2 deficiency
20. A prevalent missense substitution that modulates activity of prostatic steroid 5α-reductase
21. Biochemical and pharmacogenetic dissection of human steroid 5alpha-reductase type II
22. Microsatellite instability and loss of heterozygosity in breast cancer
23. A StuI polymorphism in the human androgen receptor gene (AR)
24. Prostate cancer risk and polymorphisms in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)
25. The biochemical and phenotypic characterization of females homozygous for 5α-reductase deficiency
26. Software Arlequin Ver.1.1: A Software for Population Genetics Data Analysis
27. Multiple geographic sources of region V 9-bp deletion haplotypes in Brazilians
28. Human races: A genetic and evolutionary perspective
29. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk
30. Androgen receptor polymorphisms: Association with prostate cancer risk, relapse and overall survival
31. Evidence that CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men
32. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: A population-based case-control study in China
33. The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer
34. The CAG and GGC microsatellites of androgen receptor gene are in linkage disequilibrium in men with prostate cancer
35. Sequence variation in the androgen receptor gene is not a common determinant of male sexual orientation
36. The V89L polymorphism in the 5alpha-reductase type 2 gene and risk of prostate cancer
37. Association of SRD5A2 genotype and pathological characteristics of prostate tumors
38. A polymorphism in the CYP17 gene is associated with prostate cancer risk
39. Prostate cancer associated with CYP17 genotype
40. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect